-
Axicabtagene ciloleucel, sold
under the
brand name Yescarta, is a
medication used for the
treatment for
large B-cell
lymphoma that has
failed conventional...
-
originally for B-cell
precursor acute lymphoblastic leukemia (B-ALL), and
axicabtagene ciloleucel (Yescarta),
marketed by Kite
Pharma originally for diffuse...
- 7th in its
annual list of the
preceding year's 50
Smartest Companies.
Axicabtagene ciloleucel (KTE-C19, ZUMA-3, YESCARTA) was an
investigational therapy...
-
Aflibercept ****nic
trioxide Asparagine depleters (Asparaginase#/Pegaspargase)
Axicabtagene ciloleucel Belzutifan Bexarotene Brexucabtagene autoleucel Celecoxib...
- immunotherapies. The
first 2
adoptive T-cell therapies,
tisagenlecleucel and
axicabtagene ciloleucel, were
approved by the FDA in 2017.
Another approach is adoptive...
-
Aflibercept ****nic
trioxide Asparagine depleters (Asparaginase#/Pegaspargase)
Axicabtagene ciloleucel Belzutifan Bexarotene Brexucabtagene autoleucel Celecoxib...
-
Aflibercept ****nic
trioxide Asparagine depleters (Asparaginase#/Pegaspargase)
Axicabtagene ciloleucel Belzutifan Bexarotene Brexucabtagene autoleucel Celecoxib...
-
Aflibercept ****nic
trioxide Asparagine depleters (Asparaginase#/Pegaspargase)
Axicabtagene ciloleucel Belzutifan Bexarotene Brexucabtagene autoleucel Celecoxib...
-
advance in
treating refractory and
relapsed DLBCL, NOS (tisagenlecleucel,
axicabtagene ciloleucel,
lisocabtagene maraleucel).
Chimeric antigen receptor T cells...
-
Aflibercept ****nic
trioxide Asparagine depleters (Asparaginase#/Pegaspargase)
Axicabtagene ciloleucel Belzutifan Bexarotene Brexucabtagene autoleucel Celecoxib...
